{
    "code": "02022988",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022988",
    "time": "2020-07-10 06:26:35",
    "許可證字號": "衛署藥輸字第022988號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/09\/04",
    "發證日期": "89\/09\/04",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202298800",
    "中文品名": "超－速避凝注射液",
    "英文品名": "FRAXIPARINE FORTE INJECTABLE SOLUTION",
    "適應症": "深部靜脈血栓性栓塞症。",
    "劑型": "270注射劑",
    "包裝": "注射針筒 支裝 盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "NADROPARINE CALCIUM",
    "限制項目": "02輸　入",
    "申請商名稱": "6401022326  安沛國際有限公司",
    "申請商地址": "台北市大安區敦化南路二段207號20樓",
    "主製造廠": [
        {
            "製造廠名稱": "FFR0274000  Aspen Notre Dame De Bondeville",
            "製造廠廠址": "1,RUE DE l&#39;ABBAYE 76960 NOTRE DAME DE BONDEVILLE, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012401510",
            "成分名稱": "NADROPARINE CALCIUM",
            "含量描述": "19,000",
            "含量": "",
            "單位": "IU AN"
        }
    ]
}